Mylan
May 18, 2012 at 12:58 | Source: Moneycontrol.com
Apr 25, 2012 at 12:52 | Source: Moneycontrol.com
Oct 07, 2011 at 22:42 | Source: CNBC-TV18
Sep 20, 2011 at 21:56 | Source: CNBC-TV18
Sep 20, 2011 at 20:49 | Source: PTI
News across the web »
May 25, 2012 at 09:31 | Source: DNA India
May 19, 2012 at 02:01 | Source: Business Standard
May 18, 2012 at 06:21 | Source: Forbes
May 16, 2012 at 22:16 | Source: The Hindu BusinessLine
May 02, 2012 at 05:51 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
Mylan Inc. settled a patent dispute with Sunovion Pharmaceuticals Inc. over the bronchitis and emphysema drug Brovana less than a week before a trial was set to begin. “Sunovion acknowledges that its making, using, offering to sell and selling ...
May 24, 2012 at 22:10 | Source: Bloomberg
PITTSBURGH, May 23, 2012 /PRNewswire via COMTEX/ -- Mylan Inc. (NASDAQ:MYL) today reported that Moody's Investors Service ("Moody's") has upgraded the company's credit ratings, including the "Corporate Family Rating," to Ba1 from Ba2. Following ...
May 23, 2012 at 16:56 | Source: Marketwatch
PITTSBURGH, POTTERS BAR, England and MILAN, May 24, 2012 /PRNewswire via COMTEX/ -- Mylan Inc. (NASDAQ:MYL) today announced that its UK and Italy-based subsidiaries have launched Ibandronic Acid Film Coated Tablets POM, 150 mg. This product is ...
May 24, 2012 at 16:55 | Source: Marketwatch
As Mylan (MYL) has quietly outperformed the market over the past year, it has flown under the radar as there are much more notable pharmaceutical companies. However, the company has continued to execute and the most recent case was MYL's announcement ...
May 22, 2012 at 06:13 | Source: Seekingalpha.com
PITTSBURGH and NEW YORK, May 18, 2012 /PRNewswire/ -- The Drug Store News Group, the Pharmacist Society and Mylan Inc., one of the world's leading generics and specialty pharmaceutical companies, are pleased to announce an exclusive sponsorship to expand ...
May 18, 2012 at 13:27 | Source: PR Newswire
(RTTNews.com) - Mylan Inc. (MYL) announced Thursday that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties' patent litigation relating to ...
May 24, 2012 at 20:01 | Source: NASDAQ
Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovan
Mylan Inc. (Nasdaq: MYL) today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties' patent litigation relating to Sunovion's Brovana ...
May 27, 2012 at 13:09 | Source: PR-USA.net
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clopidogrel Tablets USP, 75 ...
May 18, 2012 at 04:37 | Source: News-Medical.Net
PITTSBURGH (AP) -- Mylan Inc. said Friday that it is selling a low-cost generic version of the cholesterol drug Lipitor in five European countries. Mylan said it is selling its generic version in the U.K., Ireland, France, Belgium and the ...
May 27, 2012 at 10:25 | Source: Yahoo Finance
Mylan Pharmaceuticals Inc., a subsidiary of generic pharma major Mylan Inc. (MYL), recently announced that it has received final approval from the U.S. Food & Drug Administration (:FDA) for its generic version of Boehringer Ingelheim’s ...
May 24, 2012 at 21:05 | Source: Yahoo Finance